Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11845957
Models of tauopathy
granted -
US 11845959
Identification of factor that promotes human HSC self-renewal
granted -
US 11845990
Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
granted -
US 11845965
Regulation of gene expression using engineered nucleases
granted -
US 11839596
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 11839649
Compositions comprising recombinant probiotic bacteria and methods of use thereof
granted -
US 11840690
Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat
granted -
US 11840689
Method of treating fatty liver disease
granted -
US 11840581
Ξ±4Ξ²7 thioether peptide dimer antagonists
granted -
US 11839599
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 11839594
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 11839631
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
granted -
US 11840686
Modulation of prekallikrein (PKK) expression
granted -
US 11840704
Adeno-associated virus variant capsids and methods of use thereof
granted -
US 11840575
Engineered immune cells targeting BCMA and their uses thereof
granted -
US 11840497
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
granted -
US 11840525
Use of AURKB small-molecule inhibitors for treatment of non-small cell lung cancer
granted -
US 11840688
Compositions and methods for inhibiting gene expression of Hif2alpha
granted -
US 11839676
System, method, and kit for selecting and preparing customized cosmetics
granted -
US 11839598
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 11839629
Methods and compositions to modulate hair growth
granted -
US 11839619
Methods for treatment of pediatric systemic mastocytosis
granted -
US 11839623
Antiviral prodrugs and formulations thereof
granted -
US 11839616
Ocular pharmaceutical compositions
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.